Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - metoclopramide hydrochloride - tablets - metoclopramide hydrochloride 10 mg - metoclopramide - metoclopramide - metoclopramide is an antiemetic and stimulates gi motility. adult population :pramin is indicated in adults for: - prevention of postoperative nausea and vomiting (ponv)- prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv)- prevention of nausea and vomiting caused by radiation therapy- symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. in migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption.- diabetic gastroparesis pediatric population:pramin is indicated in children aged 1 to 18 years for: - second line-therapy: treatment of established postoperative nausea and vomiting (ponv)- second-line therapy: prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv)

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - lozenges - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine - for the relief of severe sore throat. relief of mouth and throat infections.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - lozenges - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine - for the relief of severe sore throat. relief of mouth and throat infections.